GPT and type 2 diabetes mellitus: Neither ALT nor GGT have high reliability individually as point estimates to confirm or exclude the presence of MASLD9, 18 but in type 2 diabetes cohorts, 57% have at least one and 27% have two or more abnormal LFT tests.19